APA (7th ed.) Citation

Li, Y., Dunn, Z. S., Garcia Jr., G., Carmona, C., Zhou, Y., Lee, D., . . . Yang, L. (2022). Development of off-the-shelf hematopoietic stem cell-engineered invariant natural killer T cells for COVID-19 therapeutic intervention. Stem Cell Research & Therapy, 13(1), 1. https://doi.org/10.1186/s13287-022-02787-2

Chicago Style (17th ed.) Citation

Li, Yan-Ruide, et al. "Development of Off-the-shelf Hematopoietic Stem Cell-engineered Invariant Natural Killer T Cells for COVID-19 Therapeutic Intervention." Stem Cell Research & Therapy 13, no. 1 (2022): 1. https://doi.org/10.1186/s13287-022-02787-2.

MLA (9th ed.) Citation

Li, Yan-Ruide, et al. "Development of Off-the-shelf Hematopoietic Stem Cell-engineered Invariant Natural Killer T Cells for COVID-19 Therapeutic Intervention." Stem Cell Research & Therapy, vol. 13, no. 1, 2022, p. 1, https://doi.org/10.1186/s13287-022-02787-2.